![]() Soligenix Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases. | ![]() Genor Biopharma Genor Biopharma is a company that manufactures antibodies and related biological products. | ![]() Disc Medicine Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
| |||
Founding Date | Founding Date 1987 | Founding Date 2020 | Founding Date 2014 | Founding Date 2007 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Princeton, US HQ | Locations Austin, US HQ Ames, US | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations CN HQ | Locations Watertown, US HQ |
Employees | Employees 1422% decrease | Employees 333% increase | Employees 908 | Employees 22245% decrease | Employees 15585% increase |
Valuation ($) | Valuation ($) 8.7 m | Valuation ($) 35.5 m | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($11.1m) (FY, 2025) | Net income ($34m) (FY, 2023) | Net income ($397.9m) (FY, 2025) | Net income N/A | Net income ($212.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.9b | Total funding raised $ 212m | Total funding raised $ 50m |

Lumos Pharma is a biopharmaceutical company developing therapeutics for rare diseases.
View company
Roivant Sciences is a company that develops and commercializes medicines.
View company
Genor Biopharma is a company that manufactures antibodies and related biological products.
View company
Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
View company